Spermine → (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal

反応式

NCCCNCCCCNCCCN.[C@@H:15]1([O:46]P(O)(O)=O)[C@@H:20]([O:21]P(O)(O)=O)[C@H:19]([O:26]P(O)(O)=O)[C@@H:18]([O:31]P(O)(O)=O)[C@@H:17]([O:36]P(O)(O)=O)[C@H:16]1[O:41]P(O)(O)=O>>[O:21]=[CH:20][C@@H:19]([C@H:18]([C@@H:17]([C@@H:16]([CH2:15][OH:46])[OH:41])[OH:36])[OH:31])[OH:26]

参加物

反応物 2

HCID 1103Spermine

HCID 178527091HCID 178527091、化合物

生成物 1

HCID 107526(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal

実験手順

A composition contemplated by the instant invention was prepared by dissolving human insulin with spermine and phytic acid in double distilled water (“DDW”) containing NaOH. The solution was then lyophilized and suspended with sodium dodecanoate (SD), octanol and geraniol in a mixture of mineral oil, medium chain triglyceride (MCT) oil and castor oil. Components and concentrations are detailed in Table 1.

後処理

customwas prepared
distillationin double distilled water (“DDW”)
additioncontaining NaOH
additionsuspended with sodium dodecanoate (SD), octanol and geraniol in a mixture of mineral oil, medium chain triglyceride (MCT) oil and castor oil
concentrationComponents and concentrations

出典と根拠

ORDレコード: ord-d34855ce44584ab087d42f08dc818a1c
出典データセット: uspto-grants-2012_08
DOI: 10.6084/m9.figshare.5104873.v1
特許番号: US08241670B2

反応ノート

読み込み中…

参加物